The DOI matches its Crossref record; 90 of the 90 references it cites were found in a registry or an index.
Drug Addiction
Abstract
The neuropsychiatric mechanisms of drug addiction are complex, fascinating, and clinically important. This article reviews the genetic factors, receptor-mediated processes, and anatomical structures involved in drug addiction.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Substance use causes biological changes to the brain’s reward system, requiring repeated and/or increased doses to maintain allostasis and prevent unpleasant withdrawal symptoms (Cami & Farre, 2003).”
From “I don’t want to take buprenorphine for the rest of my life”: Acceptance and Commitment Therapy for a Client Struggling to Reduce Low-Dose Buprenorphine (a Hermeneutic Single-Case Efficacy Design) (2023) · cites this paper as Cami & Farre, 2003
In the citing paper
“It may be that, while opioid-substitution medication is required to manage the acute difficulties of withdrawal, ACT addresses the underlying psychological difficulties perpetuating substance misuse (Cami & Farre, 2003; Smout et al., 2010).”
From “I don’t want to take buprenorphine for the rest of my life”: Acceptance and Commitment Therapy for a Client Struggling to Reduce Low-Dose Buprenorphine (a Hermeneutic Single-Case Efficacy Design) (2023) · cites this paper as Cami & Farre, 2003
Citations
Cites
1 retracted
Ricaurte, G. A., Yuan, J., Hatzidimitriou, G., Cord, B. J., & McCann, U. D. (2002) · Science · doi:10.1126/science.1074501 · Cited by 179
RetractedDrug Addiction, Dysregulation of Reward, and Allostasis
Koob, G. (2001) · Neuropsychopharmacology · doi:10.1016/s0893-133x(00)00195-0 · Cited by 2,953
Goldstein, R. Z., & Volkow, N. D. (2002) · American Journal of Psychiatry · doi:10.1176/appi.ajp.159.10.1642 · Cited by 2,667
Drug Dependence, a Chronic Medical Illness
McLellan, A. T., Lewis, D. C., O'Brien, C. P., & Kleber, H. D. (2000) · JAMA · doi:10.1001/jama.284.13.1689 · Cited by 2,622
Drug abuse: hedonic homeostatic dysregulation
Koob, G. F., & Moal, M. L. (1997) · Science · doi:10.1126/science.278.5335.52 · Cited by 2,535
Molecular basis of long-term plasticity underlying addiction
Nestler, E. J. (2001) · Nature reviews. Neuroscience · doi:10.1038/35053570 · Cited by 1,893
Robinson, T. E., & Berridge, K. C. (2003) · Annual Review of Psychology · doi:10.1146/annurev.psych.54.101601.145237 · Cited by 1,509
Incentive-sensitization and addiction
Robinson, T. E., & Berridge, K. C. (2001) · Addiction · doi:10.1046/j.1360-0443.2001.9611038.x · Cited by 1,435
Addiction and the brain: The neurobiology of compulsion and its persistence
Hyman, S. E., & Malenka, R. C. (2001) · Nature reviews. Neuroscience · doi:10.1038/35094560 · Cited by 1,337
Molecular and Cellular Basis of Addiction
Nestler, E. J., & Aghajanian, G. K. (1997) · Science · doi:10.1126/science.278.5335.58 · Cited by 1,295
Endocannabinoid Signaling in the Brain
Wilson, R. I., & Nicoll, R. A. (2002) · Science · doi:10.1126/science.1063545 · Cited by 1,280
Addiction, Dopamine, and the Molecular Mechanisms of Memory
Berke, J. D., & Hyman, S. E. (2000) · Neuron · doi:10.1016/s0896-6273(00)81056-9 · Cited by 1,184
Drugs of Abuse and Stress Trigger a Common Synaptic Adaptation in Dopamine Neurons
Saal, D., Dong, Y., Bonci, A., & Malenka, R. C. (2003) · Neuron · doi:10.1016/s0896-6273(03)00021-7 · Cited by 1,147
The dopamine hypothesis of reward: past and current status
Spanagel, R., & Weiss, F. (1999) · Trends in Neurosciences · doi:10.1016/s0166-2236(99)01447-2 · Cited by 977
Neurobiology of relapse to heroin and cocaine seeking: a review
Shalev, U., Grimm, J. W., & Shaham, Y. (2002) · Pharmacological Reviews · doi:10.1124/pr.54.1.1 · Cited by 880
Zammit, S., Allebeck, P., Andreasson, S., Lundberg, I., & Lewis, G. (2002) · BMJ · doi:10.1136/bmj.325.7374.1199 · Cited by 871
Understanding polydrug use: review of heroin and cocaine co‐use
Leri, F., Bruneau, J., & Stewart, J. (2002) · Addiction · doi:10.1046/j.1360-0443.2003.00236.x · Cited by 807
Cognitive Functioning of Long-term Heavy Cannabis Users Seeking Treatment
Solowij, N. (2002) · JAMA · doi:10.1001/jama.287.9.1123 · Cited by 798
Salvinorin A: A potent naturally occurring nonnitrogenous κ opioid selective agonist
Roth, B. L., Baner, K., Westkaemper, R., Siebert, D., Rice, K. C., Steinberg, S., Ernsberger, P., & Rothman, R. B. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.182234399 · Cited by 784
Hall, W., & Solowij, N. (1998) · The Lancet · doi:10.1016/s0140-6736(98)05021-1 · Cited by 778
Psychomotor stimulant addiction: a neural systems perspective
Everitt, B. J., & Wolf, M. E. (2002) · The Journal of Neuroscience · doi:10.1523/jneurosci.22-09-03312.2002 · Cited by 700
Disruption of CREB function in brain leads to neurodegeneration
Mantamadiotis, T., Lemberger, T., Bleckmann, S. C., Kern, H., Kretz, O., Villalba, A. M., Tronche, F., Kellendonk, C., Gau, D., Kapfhammer, J., et al. (2002) · Nature Genetics · doi:10.1038/ng882 · Cited by 684
ΔFosB: A sustained molecular switch for addiction
Nestler, E. J., Barrot, M., & Self, D. W. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.191352698 · Cited by 640
A Comparison of Levomethadyl Acetate, Buprenorphine, and Methadone for Opioid Dependence
Johnson, R. E., Chutuape, M. A., Strain, E. C., Walsh, S. L., Stitzer, M. L., & Bigelow, G. E. (2000) · New England Journal of Medicine · doi:10.1056/nejm200011023431802 · Cited by 623
Exploring the opioid system by gene knockout
Kieffer, B. L., & Gavériaux-Ruff, C. (2002) · Progress in Neurobiology · doi:10.1016/s0301-0082(02)00008-4 · Cited by 620
Naltrexone in the Treatment of Alcohol Dependence
Krystal, J. H., Cramer, J. A., Krol, W. F., Kirk, G. F., & Rosenheck, R. A. (2001) · New England Journal of Medicine · doi:10.1056/nejmoa011127 · Cited by 618
Dose-related neurocognitive effects of marijuana use
Bolla, K. I., Brown, K., Eldreth, D. A., Tate, K., & Cadet, J. L. (2002) · Neurology · doi:10.1212/01.wnl.0000031422.66442.49 · Cited by 609
Drug addiction as dopamine-dependent associative learning disorder
Chiara, G. D. (1999) · European Journal of Pharmacology · doi:10.1016/s0014-2999(99)00372-6 · Cited by 607
Franklin, T. R., Acton, P. D., Maldjian, J. A., Gray, J. D., Croft, J. R., Dackis, C. A., O’Brien, C. P., & Childress, A. R. (2002) · Biological Psychiatry · doi:10.1016/s0006-3223(01)01269-0 · Cited by 599
Fudala, P. J., Bridge, T. P., Herbert, S., Williford, W. O., Chiang, C. N., Jones, K., Collins, J., Raisch, D., Casadonte, P., Goldsmith, R. J., et al. (2003) · New England Journal of Medicine · doi:10.1056/nejmoa022164 · Cited by 577
D2 dopamine receptor gene in psychiatric and neurologic disorders and its phenotypes
Noble, E. P. (2003) · American Journal of Medical Genetics Part B: Neuropsychiatric Genetics · doi:10.1002/ajmg.b.10005 · Cited by 501
Cellular and synaptic mechanisms of nicotine addiction
Mansvelder, H. D., & McGehee, D. S. (2002) · Journal of Neurobiology · doi:10.1002/neu.10148 · Cited by 450
Rasmussen, K., Beitner‐Johnson, D., Krystal, J. H., Aghajanian, G. K., & Nestler, E. J. (1990) · Journal of Neuroscience · doi:10.1523/jneurosci.10-07-02308.1990 · Cited by 439
Molecular Neurobiology of Addiction
Nestler, E. J. (2001) · American Journal on Addictions · doi:10.1080/105504901750532094 · Cited by 416
Robinson, T. E., Gorny, G., Mitton, E., & Kolb, B. E. (2001) · Synapse · doi:10.1002/1098-2396(20010301)39:3 · Cited by 411
Evidence for long-term neurotoxicity associated with methamphetamine abuse
Ernst, T., Chang, L., Leonido–Yee, M., & Speck, O. (2000) · Neurology · doi:10.1212/wnl.54.6.1344 · Cited by 373
Kreek, M. J., LaForge, K. S., & Butelman, E. R. (2002) · Nature Reviews Drug Discovery · doi:10.1038/nrd897 · Cited by 371
Robbe, D., Alonso, G., Duchamp, F., Bockaert, J., & Manzoni, O. J. (2001) · Journal of Neuroscience · doi:10.1523/jneurosci.21-01-00109.2001 · Cited by 367
A missense mutation in human fatty acid amide hydrolase associated with problem drug use
Sipe, J. C., Chiang, K. P., Gerber, A. L., Beutler, E., & Cravatt, B. F. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.082235799 · Cited by 354
Regulation of Opioid Receptor Trafficking and Morphine Tolerance by Receptor Oligomerization
He, L., Fong, J. C., von Zastrow, M., & Whistler, J. L. (2002) · Cell · doi:10.1016/s0092-8674(02)00613-x · Cited by 339
Behavioral Neurobiology of Alcohol Addiction: Recent Advances and Challenges
Weiss, F., & Porrino, L. J. (2002) · Journal of Neuroscience · doi:10.1523/jneurosci.22-09-03332.2002 · Cited by 327
Management of Cocaine Abuse and Dependence
Mendelson, J. H., & Mello, N. K. (1996) · New England Journal of Medicine · doi:10.1056/nejm199604113341507 · Cited by 291
Elevated levels of GluR1 in the midbrain: a trigger for sensitization to drugs of abuse?
Carlezon, W. A., & Nestler, E. J. (2002) · Trends in Neurosciences · doi:10.1016/s0166-2236(02)02289-0 · Cited by 281
Chronic morphine induces visible changes in the morphology of mesolimbic dopamine neurons.
Sklair‐Tavron, L., Shi, W. X., Lane, S. B., Harris, H. W., Bunney, B. S., & Nestler, E. J. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.20.11202 · Cited by 279
Neural Systems Underlying Opiate Addiction
De Vries, T. J., & Shippenberg, T. S. (2002) · The Journal of Neuroscience · doi:10.1523/jneurosci.22-09-03321.2002 · Cited by 270
Patients with Alcohol Problems
O’Connor, P. G., & Schottenfeld, R. S. (1998) · New England Journal of Medicine · doi:10.1056/nejm199802263380907 · Cited by 267
Picciotto, M. R., & Corrigall, W. A. (2002) · Journal of Neuroscience · doi:10.1523/jneurosci.22-09-03338.2002 · Cited by 265
Drug therapy for alcohol dependence
Swift, R. M. (1999) · New England Journal of Medicine · doi:10.1056/nejm199905133401907 · Cited by 255
Camí, J., Farré, M., Mas, M., Roset, P. N., Poudevida, S., Mas, A., San, L., & de la Torre, R. (2000) · Journal of Clinical Psychopharmacology · doi:10.1097/00004714-200008000-00010 · Cited by 234
Self-citationRao, Y., Hoffmann, E. B., Zia, M., Bodin, L., Zeman, M., Sellers, E. M., & Tyndale, R. F. (2000) · Molecular Pharmacology · doi:10.1124/mol.58.4.747 · Cited by 231
Subjective and hormonal effects of 3,4-methylenedioxymethamphetamine (MDMA) in humans
Harris, D. S., Baggott, M., Mendelson, J. H., Mendelson, J. E., & Jones, R. T. (2002) · Psychopharmacology · doi:10.1007/s00213-002-1131-1 · Cited by 229
Berrendero, F., Kieffer, B. L., & Maldonado, R. J. (2002) · Journal of Neuroscience · doi:10.1523/jneurosci.22-24-10935.2002 · Cited by 225
Marijuana Abstinence Effects in Marijuana Smokers Maintained in Their Home Environment
Budney, A. J., Hughes, J. R., Moore, B. A., & Novy, P. L. (2001) · Archives of General Psychiatry · doi:10.1001/archpsyc.58.10.917 · Cited by 223
Nestler, E. J. (2000) · Nature Genetics · doi:10.1038/81570 · Cited by 215
A Genome-Wide Search for Genes That Relate to a Low Level of Response to Alcohol
Schuckit, M. A., Edenberg, H. J., Kalmijn, J. A., Wetherill, L. F., Smith, T. L., Reich, T., Bierut, L. J., Goate, A., & Foroud, T. (2001) · Alcoholism Clinical and Experimental Research · doi:10.1111/j.1530-0277.2001.tb02217.x · Cited by 208
Cannabinoid Addiction: Behavioral Models and Neural Correlates
Maldonado, R. J., & de Fonseca, F. R. (2002) · Journal of Neuroscience · doi:10.1523/jneurosci.22-09-03326.2002 · Cited by 205
Genetic Contributions to Addiction
Crabbe, J. C. (2002) · Annual Review of Psychology · doi:10.1146/annurev.psych.53.100901.135142 · Cited by 203
Intravenous self-administration of the cannabinoid CB1 receptor agonist WIN 55,212-2 in rats
Fattore, L., Cossu, G., Martellotta, C., & Fratta, W. (2001) · Psychopharmacology · doi:10.1007/s002130100734 · Cited by 187
Drugs of abuse: behavioural principles, methods and terms
Stolerman, I. P. (1992) · Trends in Pharmacological Sciences · doi:10.1016/0165-6147(92)90059-f · Cited by 182
Drug abuse potential evaluation in animals
Balster, R. L. (1991) · British Journal of Addiction · doi:10.1111/j.1360-0443.1991.tb01747.x · Cited by 181
Retention rate and illicit opioid use during methadone maintenance interventions: a meta-analysis
Farré, M., Mas, A., Torrens, M., Moreno, V. R., & Camı́, J. (2002) · Drug and Alcohol Dependence · doi:10.1016/s0376-8716(01)00171-5 · Cited by 180
Self-citationLappalainen, J., Kranzler, H. R., Malison, R. T., Price, L. H., van Dyck, C. H., Rosenheck, R. A., Cramer, J. A., Southwick, S. M., Charney, D. S., Krystal, J. H., et al. (2002) · Archives of General Psychiatry · doi:10.1001/archpsyc.59.9.825 · Cited by 175
Substance Misuse in Patients with Schizophrenia
Kavanagh, D. J., McGrath, J. J., Saunders, J. B., Dore, G. M., & Clark, D. (2002) · Drugs · doi:10.2165/00003495-200262050-00003 · Cited by 156
Individual Differences in the Biphasic Effects of Ethanol
Holdstock, L., & de Wit, H. (1998) · Alcoholism Clinical and Experimental Research · doi:10.1111/j.1530-0277.1998.tb05897.x · Cited by 153
CB1 cannabinoid receptor antagonist-induced opiate withdrawal in morphine-dependent rats
Navarro, M., Chowen, J., Carrera, M. R. A., del Arco, I., Villanúa, M. A., Martin, Y., Roberts, A. J., Koob, G. F., & de Fonseca, F. R. (1998) · NeuroReport · doi:10.1097/00001756-199810260-00012 · Cited by 152
Office-Based Treatment of Opioid-Dependent Patients
Fiellin, D. A., & O'Connor, P. G. (2002) · New England Journal of Medicine · doi:10.1056/nejmcp013579 · Cited by 148
Study of cannabinoid dependence in animals
Maldonado, R. J. (2002) · Pharmacology & Therapeutics · doi:10.1016/s0163-7258(02)00254-1 · Cited by 136
Molecular Mechanisms for Heterologous Sensitization of Adenylate Cyclase
Watts, V. J. (2002) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.302.1.1 · Cited by 135
Learning about addiction from the genome
Nestler, E. J., & Landsman, D. (2001) · Nature · doi:10.1038/35057015 · Cited by 133
Cocaine’s Effects on Neuroendocrine Systems: Clinical and Preclinical Studies
Mello, N. K., & Mendelson, J. H. (1997) · Pharmacology Biochemistry and Behavior · doi:10.1016/s0091-3057(96)00433-9 · Cited by 133
Pharmacokinetic considerations in abuse liability evaluation
Farré, M., & Camı́, J. (1991) · British Journal of Addiction · doi:10.1111/j.1360-0443.1991.tb01754.x · Cited by 112
Self-citationSubstance abuse vulnerability loci: converging genome scanning data
Uhl, G. R., Liu, Q., & Naiman, D. Q. (2002) · Trends in Genetics · doi:10.1016/s0168-9525(02)02719-1 · Cited by 94
ΔFosB: a molecular switch underlying long-term neural plasticity
Kelz, M. B., & Nestler, E. J. (2000) · Current Opinion in Neurology · doi:10.1097/00019052-200012000-00017 · Cited by 93
Kreek, M. J. (2001) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2001.tb03557.x · Cited by 82
Experimental Genetic Approaches to Addiction
Laakso, A., Mohn, A. R., Gainetdinov, R. R., & Caron, M. G. (2002) · Neuron · doi:10.1016/s0896-6273(02)00972-8 · Cited by 81
Crack cocaine and cocaine hydrochloride. Are the differences myth or reality?
Hatsukami, D. K. (1996) · JAMA · doi:10.1001/jama.276.19.1580 · Cited by 76
Maddux, J. F., & Desmon, D. P. (2000) · Addiction · doi:10.1046/j.1360-0443.2000.9556611.x · Cited by 64
Novelty seeking as a predictor of treatment retention for heroin dependent cocaine users
Helmus, T. (2001) · Drug and Alcohol Dependence · doi:10.1016/s0376-8716(00)00153-8 · Cited by 64
Alprazolam absorption kinetics affects abuse liability
Mumford, G. K., Evans, S. M., Fleishaker, J. C., & Griffiths, R. R. (1995) · Clinical Pharmacology & Therapeutics · doi:10.1016/0009-9236(95)90162-0 · Cited by 63
Hypercortisolism after opioid discontinuation in rapid detoxification of heroin addicts
CAMÍ, J., GILABERT, M., SAN, L., & DE LA TORRE, R. (1992) · British Journal of Addiction · doi:10.1111/j.1360-0443.1992.tb02001.x · Cited by 55
Self-citationInhibition of Cytochrome P450 2D6 Modifies Codeine Abuse Liability
Kathiramalainathan, K., Kaplan, H. L., Romach, M. K., Busto, U. E., Li, N.-Y., Säwe, J., Tyndale, R. F., & Sellers, E. M. (2000) · Journal of Clinical Psychopharmacology · doi:10.1097/00004714-200008000-00008 · Cited by 54
Treatment of Heroin (Diamorphine) Addiction
Gonzalez, G. M., Oliveto, A. H., & Kosten, T. R. (2002) · Drugs · doi:10.2165/00003495-200262090-00004 · Cited by 46
Abuse liability of flunitrazepam among methadone-maintained patients
Farré, M., Terán, M.-T., Roset, P. N., Más, M., Torrens, M., & Camı́, J. (1998) · Psychopharmacology · doi:10.1007/s002130050793 · Cited by 42
Self-citationModulation of rate of onset and intensity of drug effects reduces abuse potential in healthy males
Roset, P. N., Farré, M., de la Torre, R., Más, M., Menoyo, E., Hernández, C., & Camı́, J. (2001) · Drug and Alcohol Dependence · doi:10.1016/s0376-8716(01)00127-2 · Cited by 35
Self-citationZhang, L., Hosoi, M., Fukuzawa, M., Sun, H., Rawlings, R. R., & Weight, F. F. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m207683200 · Cited by 27
Identification of the Endogenous Cannabinoid System through Integrative Pharmacological Approaches
Martin, B. R. (2002) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.301.3.790 · Cited by 25
Benzodiazepines and the other sedative-hypnotics
(2016) · Oxford University Press eBooks · doi:10.1093/med/9780198714750.003.0013 · Cited by 14
Human drug abuse liability: testing times ahead
Camı́, J. (1991) · British Journal of Addiction · doi:10.1111/j.1360-0443.1991.tb01741.x · Cited by 6
Self-citationBehavioral and Molecular Aspects of Alcohol Craving and Relapse
Spanagel, R. (2003) · Humana Press eBooks · doi:10.1007/978-1-59259-343-9_15 · Cited by 2
Behavioral and Molecular Aspects of Alcohol Craving and Relapse
Spanagel, R. (2003) · Humana Press eBooks · doi:10.1385/1-59259-343-7:295 · Cited by 1
Research works printed but not linked: 10
- Sarnyai Z, 2001, Pharmacol Rev, 53, 209
- Farre M, 1997, J Pharmacol Exp Ther, 283, 164
- Abraham HD, McCann UD, Ricaurte GA. Psychedelic drugs. In: Davis KL, Charney D, Coyle JT, Nemeroff C, eds. Neuropsychopharmacology: the fifth generation of progress. Philadelphia: Lippincott Williams & Wilkins, 2002:1545-56.
- Kalivas PW. Neurocircuitry of addiction. In: Davis KL, Charney D, Coyle JT, Nemeroff C, eds. Neuropsychopharmacology: the fifth generation of progress. Philadelphia: Lippincott Williams & Wilkins, 2002:1357-66.
- Konipsky KL, Hyman SE. Molecular and cellular biology of addiction. In: Davis KL, Charney D, Coyle JT, Nemeroff C, eds. Neuropsychopharmacology: the fifth generation of progress. Philadelphia: Lippincott Williams & Wilkins, 2002:1367-79.
- Volkow ND, Fowler JS. Application of imaging technologies in the investigation of drug addiction. In: Davis KL, Charney D, Coyle JT, Nemeroff C, eds. Neuropsychopharmacology: the fifth generation of progress. Philadelphia: Lippincott Williams & Wilkins, 2002:1475-90.
- Merlo E, Heidbreder C, Mugnaini M, Teneggi V. Molecular and behavioral aspects of nicotine dependence and reward. In: Maldonado R, ed. Molecular biology of drug addiction. Totowa, N.J.: Humana Press, 2002:315-38.
- Taylor DA, 2001, J Pharmacol Exp Ther, 297, 11
- Caille S, 1999, J Pharmacol Exp Ther, 290, 881
- Duman RS, 2001, J Pharmacol Exp Ther, 299, 401
Cited by
Sorted by citations
Kleindorfer, D. O., Towfighi, A., Chaturvedi, S., Cockroft, K. M., Gutierrez, J., Lombardi-Hill, D., Kamel, H., Kernan, W. N., Kittner, S. J., Leira, E. C., et al. (2021) · Stroke · doi:10.1161/str.0000000000000375 · Cited by 3,237
Meschia, J. F., Bushnell, C., Boden-Albala, B., Braun, L. T., Bravata, D. M., Chaturvedi, S., Creager, M. A., Eckel, R. H., Elkind, M. S. V., Fornage, M., et al. (2014) · Stroke · doi:10.1161/str.0000000000000046 · Cited by 2,650
Primary Prevention of Ischemic Stroke
Goldstein, L. B., Adams, R. J., Alberts, M. J., Appel, L. J., Brass, L. M., Bushnell, C., Culebras, A., DeGraba, T. J., Gorelick, P. B., Guyton, J. R., et al. (2006) · Stroke · doi:10.1161/01.str.0000223048.70103.f1 · Cited by 1,376
Goldstein, L. B., Bushnell, C. D., Adams, R. J., Appel, L. J., Braun, L. T., Chaturvedi, S., Creager, M. A., Culebras, A., Eckel, R. H., Hart, R. G., et al. (2011) · Stroke · doi:10.1161/str.0b013e3181fcb238 · Cited by 1,306
Involvement of the endocannabinoid system in drug addiction
Maldonado, R. J., Valverde, O., & Berrendero, F. (2006) · Trends in Neurosciences · doi:10.1016/j.tins.2006.01.008 · Cited by 601
Metadata
- Authors
- Camí, J., & Farré, M.
- Venue
- New England Journal of Medicine
- Publisher
- Massachusetts Medical Society
- Published
- 2003-09-04
- Volume
- 349
- Issue
- 10
- Pages
- 975-986
- ISSN
- 0028-4793 (ISSN-L)
- 1533-4406
- OpenAlex
- W4244161634
- Semantic Scholar
- f25e484d34221266586072b4e216a5a3d393e8f6
- Cited by
- 477
- References
- 89
- Citations by year
- 2026: 3 · 2025: 19 · 2024: 16 · 2023: 13 · 2022: 20 · 2021: 29 · 2020: 19 · 2019: 12 · 2018: 21 · 2017: 20 · 2016: 25 · 2015: 15 · 2014: 24 · 2013: 28 · 2012: 14
- FWCI
- 2.43
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- New England Journal of Medicine (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neurotransmitter Receptor Influence on Behavior
- Health Sciences › Medicine › Epidemiology › Substance Abuse Treatment and Outcomes
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neuroscience and Neuropharmacology Research
- Keywords
- drug addiction, genetic factors, neuroanatomy, addiction genetics, neurotransmitter receptors
- MeSH terms
- Ethanol, Animals, Cannabinoids, Cocaine, Disease Models, Animal, Dopamine, Humans, Narcotics, Nicotine, Recurrence, Reinforcement, Psychology, Substance Withdrawal Syndrome, Substance-Related Disorders
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
